Dawex Launches a Corporate Data Hub Solution to Break Down Data Silos and Facilitate Data Circulation within an Organization
25.9.2023 08:30:00 CEST | Business Wire | Press Release
Dawex, the leader in Data Exchange solutions, today announced the launch of a Corporate Data Hub solution enabling each multinational corporation and large organization to accelerate internal data circulation within its multiple business units, departments & subsidiaries. Relying on Dawex Data Exchange technology, a Corporate Data Hub fosters true data collaboration within entities and gathers a powerful internal data ecosystem, in compliance with data regulations and the organization’s data governance policies. Implementing a Corporate Data Hub within an organization accelerates information sharing, rationalizes data sourcing, improves operational efficiency, facilitates data exchange governance, and triggers more informed decisions to meet business, strategic & CSR objectives.
Acting as a federated Data Exchange solution, a Corporate Data Hub brings significant value on top of existing data fabrics or data catalogs. It enables data providers within an organization to publish, distribute and market their data products internally in a trusted, secure and compliant environment. Data providers decide who accesses the data, grant specific license use, trace data transactions and can also set internal transfer prices. Simultaneously, data acquirers within the same organization, either coming from the same team or from a different department, business unit or subsidiary, within the same country or from another regional location, can easily search, discover and access these data products, breaking down silos and nurturing cross-border, cross-entity knowledge sharing while controlling accesses.
Dawex Corporate Data Hub solution is built on state-of-the-art technologies such as distributed and open architectures, open standard, sovereign identities, and the Gaia-X Trust framework, to complement and seamlessly interoperate with existing data systems in large corporations. For example, it integrates easily with internal identity managers, API managers, data fabrics or storage infrastructures to create immediate value without requiring a long and costly IT transformation.
Dawex Data Exchange technology brings security, compliance, trust, flexibility and open architecture to organizations seeking to build a strong data ecosystem and operate data exchanges at drastically reduced time and effort. Additionally, Dawex Data Exchange Platform solutions comply with local data regulations such as GDPR, DGA in Europe, APPI in Japan, CCPA in the US, or LGPD in Brazil.
“In the age of data-driven decision-making, Corporate Data Hubs are an impactful solution for organizations seeking to internally unlock the full potential of their data”, says Laurent Lafaye, Dawex co-CEO. “By fostering data collaboration, breaking down silos, and facilitating data circulation, a Corporate Data Hub empowers an organization to drive innovation, meet decarbonation objectives and achieve operational excellence.”
A Corporate Data Hub can easily be combined with other Data Exchange models, such as a Data Marketplace or Industry Data Hub, as organizations explore hybrid models to adapt to their evolving Data Exchange needs and requirements, providing flexibility in data collaboration strategies.
About Dawex
Dawex is the leader in Data Exchange solutions to distribute or share data products, with trust, for any business case, in compliance with data regulations. With Dawex Data Exchange technology, organizations create data ecosystems and data spaces such as Data Marketplaces, Corporate Data Hubs and Industry Data Hubs to address economic, environmental and decarbonation challenges. Awarded Technology Pioneer by the World Economic Forum, Dawex is the initiator of an international standardization program on Trusted Data Transaction. Created in 2015, Dawex is headquartered in France, expanding business operations to Europe, Asia, North America and the Middle East.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230921677503/en/
Contact information
Press:
Isabelle Joulot
Vice President Communications & Marketing
press@dawex.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press Release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press Release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press Release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press Release
IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio transformation and is expected to strengthen the company’s focus on its innovation-driven businesses: Taste, Scent, and Health & Biosciences. Following the transaction, IFF will be
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 patients, underscoring consistent effectiveness and safety in clinical practice. Additionally, BEQALZI™ (sonrotoclax), which was recently approved by the U.S. Food and Drug Administration, and its development in combination with BRUKINSA (ZS) highlight the potential for next-generation, time-limited treatment approaches in CLL. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: “CLL is a disease patients live with
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom